Endothelial Cell Activation Contributes to the Release of Procoagulant Microparticles During Acute Cardiac Allograft Rejection

Journal of Heart and Lung Transplantation

Volumn 27, Issue 1, 2008, Pages 38-45

  Morel, Olivier ^a,b   Ohlmann, Patrick ^a   Epailly, Eric ^a   Bakouboula, Babe ^a,b   Zobairi, Fatiha ^b,c   Jesel, Laurence ^a   Meyer, Nicolas ^d   Chenard, Marie Pierre ^e   Freyssinet, Jean Marie ^b,c   Bareiss, Pierre ^a   Mazzucotelli, Jean Philippe ^a   Toti, Florence ^b,c,e,f  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Dept Environ Med Natl Inst Publ HIth   (Norway)

^d Département de Biostatistique et d'informatique médicale   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 18; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; COLD ISCHEMIA; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FEMALE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

ACUTE DISEASE; ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BIOPSY; CYTOKINES; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CYTOADHESIN; THROMBOPLASTIN; TRANSPLANTATION, HOMOLOGOUS; ULTRACENTRIFUGATION;

EID: 37549036305     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.09.031     Document Type: Article

References (36)

1. Kobashigawa J.A., Kirklin J.K., Naftel D.C., et al. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 12 (1993) 355-366
2. Shulzhenko N., Morgun A., Franco M., et al. Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection. Braz J Med Biol Res 34 (2001) 779-784
3. Schoels M., Dengler T.J., Richter R., Meuer S.C., and Giese T. Detection of cardiac allograft rejection by real-time PCR analysis of circulating mononuclear cells. Clin Transplant 18 (2004) 513-517
4. Hsu R.B., Tsay Y.G., Lee C.M., Chen R.J., Wang S.S., and Chu S.H. Soluble inflammatory markers in coronary sinus and peripheral blood of heart transplant recipients. Clin Transplant 17 (2003) 331-337
5. Reul R.M., Fang J.C., Denton M.D., et al. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64 (1997) 1765-1774
6. Askenasy N., Yolcu E.S., Wang Z., and Shirwan H. Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection. Circulation 107 (2003) 1525-1531
7. Fahmy N.M., Yamani M.H., Starling R.C., et al. Chemokine and receptor-gene expression during early and late acute rejection episodes in human cardiac allografts. Transplantation 75 (2003) 2044-2047
8. Amir G., Rubinsky B., Basheer S.Y., et al. Improved viability and reduced apoptosis in sub-zero 21 hour preservation of transplanted heart using anti-freeze proteins. J Heart Lung Transplant 24 (2005) 1915-1929
9. Weaver J.G., McGregor C.G., Tazelaar H.D., and Badley A.D. Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation. J Heart Lung Transplant 24 (2005) 841-847
10. Aupeix K., Hugel B., Martin T., et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 99 (1997) 1546-1554
11. Sabatier F., Darmon P., Hugel B., et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51 (2002) 2840-2845
12. Chirinos J.A., Heresi G.A., Velasquez H., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45 (2005) 1467-1471
13. Morel O., Hugel B., Jesel L., et al. Sustained generation of procoagulant microparticles after acute myocardial infarction in diabetes mellitus: role of endothelial damage and platelet activation. Thromb Haemost 91 (2004) 345-353
14. Arteaga R.B., Chirinos J.A., Soriano A.O., et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 98 (2006) 70-74
15. Koga H., Sugiyama S., Kugiyama K., et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 45 (2005) 1622-1630
16. Werner N., Wassmann S., Ahlers P., Kosiol S., and Nickenig G. Circulating CD31+/Annexin-V+ Apoptotic Microparticles Correlate with Coronary Endothelial Function in Patients With Coronary Artery Disease. Arterioscler Thromb Vasc Biol (2005)
17. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 26 (2006) 2594-2604
18. Hugel B., Martinez M.C., Kunzelmann C., and Freyssinet J.M. Membrane microparticles: two sides of the coin. Physiology (Bethesda) 20 (2005) 22-27
19. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 1 (2003) 1655-1662
20. Kown M.H., Strauss H.W., Blankenberg F.G., et al. In vivo imaging of acute cardiac rejection in human patients using (99m)technetium labeled annexin-V. Am J Transplant 1 (2001) 270-277
21. Blankenberg F., Mari C., and Strauss H.W. Imaging cell death in vivo. Q J Nucl Med 47 (2003) 337-348
22. Garcia S., Chirinos J.A., Jimenez J., et al. Phenotypic assessment of endothelial microparticles in patients with heart failure and after heart transplantation: switch from cell activation to apoptosis. J Heart Lung Transplant 24 (2005) 2184-2189
23. Jimenez J.J., Jy W., Mauro L.M., Soderland C., Horstman L.L., and Ahn Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109 (2003) 175-180
24. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 Working Formulation for the Standardisation of Nomenclature in the Diagnosis of Heart Rejection. J Heart Lung Transplant 24 (2005) 1710-1720
25. Hugel B., Zobairi F., and Freyssinet J.M. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 (2004) 1846-1847
26. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., and Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
27. Josien R., Muschen M., Gilbert E., et al. Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation 66 (1998) 887-893
28. Abid Hussein M.N., Meesters E.W., Osmanovic N., Romijn F.P., Nieuwland R., and Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost 1 (2003) 2434-2443
29. Toppila S., Paavonen T., Nieminen M.S., Hayry P., and Renkonen R. Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants. Am J Pathol 155 (1999) 1303-1310
30. Pihusch V., Rank A., Steber R., et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation 81 (2006) 1405-1409
31. Tung T.C., Oshima K., Cui G., Laks H., and Sen L. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts. Am J Physiol Heart Circ Physiol 285 (2003) H964-H973
32. Grau V., Stehling O., Garn H., and Steininger B. Accumulating monocytes in the vasculature of rat renal allografts: phenotype, cytokine, inducible NO synthase, and tissue factor mRNA expression. Transplantation 71 (2001) 37-46
33. Naji A., Deschaseaux F., Racadot E., et al. Induction of tissue factor expression on human umbilical vein endothelial cells by cell-specific HLA class I antibofy: preliminary data. Transplant Proc 37 (2005) 2892-2893
34. Reverdiau-Moalic P., Watier H., Iochmann S., et al. Human allogenic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathway. J Lab Clin Med 132 (1998) 530-540
35. Holschermann H., Bohle R.M., Schmidt H., et al. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in cardiac allografts. Circulation 102 (2000) 357-363
36. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23 5 suppl (2004) S187-S193